Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
Nature Medicine2002Vol. 8(1), pp. 35–40
Citations Over TimeTop 1% of 2002 papers
Masanori Asakura, Masafumi Kitakaze, Seiji Takashima, Yulin Liao, Fuminobu Ishikura, Tsuyoshi Yoshinaka, Hiroshi Ohmoto, Koichi Node, Kiyoshi Yoshino, Hiroshi Ishiguro, Hiroshi Asanuma, Shoji Sanada, Yasushi Matsumura, Hiroshi Takeda, Shintaro Beppu, Michihiko Tada, Masatsugu Hori, Shigeki Higashiyama
Related Papers
- → A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems(2016)63 cited
- → Molecular cloning and functional characterization of a snake venom metalloprotease(1999)47 cited
- → Functional roles of the two distinct domains of halysase, a snake venom metalloprotease, to inhibit human platelet aggregation(2005)23 cited
- The Role of CD9 in Regulating TNF-α-Induced Expression of A Disintegrin and Metalloprotease 17 (ADAM17) in Aortic Endothelial Cells(2019)
- → Disintegrin and Metalloproteinase Domain-Containing Protein 10(2020)